A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric ...
Schizophrenia patients have a 10 to 25-year reduced life expectancy, with a 58% higher mortality rate than the general population. Second-generation antipsychotics, particularly long-acting ...
Schizophrenia is a serious psychiatric disorder that affects how people feel, think, and behave. It impacts approximately 1% of the population, or about 3.5 million people in the United States. This ...
Scientists who study mental disorders have long faced an inherent obstacle. When they examine a deceased person's brain, they can't tell how the brain cells functioned and interacted. And they can't ...
aDepartment of Psychiatry, Creighton School of Medicine, Creighton University Education Building, Omaha, NE 68124–237, USA bDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA Older ...
Once confined to the black market, ultra-potent marijuana is now mainstream—and research shows its dangers are anything but benign. As cannabis potency climbs ever higher, a troubling signal has ...
Caplyta (lumateperone) is a prescription drug used to treat schizophrenia in adults. It does not come as a generic drug. Caplyta comes as an oral capsule. The active ingredient in Caplyta is ...
Abstract: Clinical genetic studies have shown that if people with mental health condition have the closer blood relationship, his or her offspring will have the higher prevalence of mental diseases.
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Autism was introduced by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback